ATLANTA, USA, (CDC) – Half a million fewer US youth reported current use of e-cigarettes in 2024 compared to 2023, according to new data from the...

KalVista announces FDA acceptance of New Drug Application for sebetralstat for oral on-demand treatment of hereditary angioedema KalVista...

By Shen Pei-yao and Ko Lin TAIPEI, Taiwan, (CNA) – The Taiwan Food and Drug Administration (TFDA) has amended a regulation to allow food industry...

By Shen Pei-yao and Ko Lin TAIPEI, Taiwan, (CNA) – The Taiwan Food and Drug Administration (TFDA) has amended a regulation to allow food industry...

THURSDAY, Sept. 5, 2024 -- The maker of the ADHD drug Vyvanse has been given approval by the U.S. Drug Enforcement Administration to make more of the...

The FDA bestows an orphan drug designation to Agios' PK activator, tebapivat, for treating myelodysplastic syndromes.

The FDA bestows an orphan drug designation to Agios' PK activator, tebapivat, for treating myelodysplastic syndromes.

MONDAY, Sept. 16, 2024 -- The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of adults with moderately to...

MONDAY, Sept. 16, 2024 -- The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of adults with moderately to...

%BlogLink% %FearturedImage% %PostLink% The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the recall of Dove...